Importantly, loss of miR-204 has been associated with a stem cell-like phenotype in gliomas, and its over-expression results in reduced tumorigenicity and loss of the stemness transcription factor, SOX4[33]. The gene discussed is SOX4; the disease is central nervous system cancer.